Image

The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy

Exploring Aleeto's safety in Multiple System Atrophy patients.

Recruiting
30-75 years
All
Phase 0
  • Simplified description (AI rewritten)
  • Technical description (Original)

Aleeto Study for Multiple System Atrophy (MSA)

Multiple System Atrophy (MSA) is a serious disease where parts of the brain break down over time. This study is testing a new treatment called Aleeto to help people with MSA. Aleeto is a special protein that might help fix nerve damage. The study will check if Aleeto is safe and if it can help patients feel better.

This study lasts for 90 days, with extra follow-ups for some patients until 360 days. Patients will have to visit the center for check-ups and tests like blood tests and brain scans (MRI). Only adults between ages 30 to 75 years with MSA can join. They need to be able to walk at least 10 meters, either alone or with help.

  • The study involves regular visits and detailed tests.
  • Participation includes monitoring for 3 months, with some visits extending to 1 year.
  • Participants will be closely checked for any side effects or new symptoms.

Before starting, all participants will sign a paper agreeing to join the study. This study is approved by the Ethics Committee of Beijing Tiantan Hospital.

Print
Study details
    Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
    Multiple System Atrophy
    MSA

NCT06765733

Beijing Tiantan Hospital

17 April 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.